The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.1 - Manufacture of basic pharmaceutical products
New offshoring locations
Canada
650 jobs Number of planned job losses
Announcement Date
10 September 2026
Employment effect (start)
10 September 2026
Foreseen end date
30 September 2028
Description
GlaxoSmithKline (GSK), a British multinational pharmaceutical company, announced the closure of its Dresden plant in Germany, resulting in approximately 650 job cuts. Production will cease by September 2027, with the facility fully wound down by summer 2028.
The restructuring is driven by GSK’s decision to concentrate vaccine production at a Canadian site and to eliminate excess capacity amid declining demand for traditional vaccines.
Workers, represented by the works council and supported by the pharma-bio trade union IGBCE, have expressed strong opposition and plan to contest the decision. Regional and European political representatives also called for efforts to preserve pharmaceutical manufacturing capacity at the site.
GSK employs 66,800 people in 70 countries and operates 33 production sites. In Germany, GSK reports 2.700 employees at five sites.
Citation
Eurofound (2026), GlaxoSmithKline (GSK), Offshoring/Delocalisation in Germany, factsheet number 301061, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/301061.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...